Under Siege: Whistleblowers Unmask Political Pressures Threatening FDA's Scientific Soul

Biohaven's Breakthrough Bid: Navigating FDA Flexibility for Spinocerebellar Ataxia's Future

Biocon Biologics Secures Landmark USFDA Approval for Critical Antibacterial Drug

FDA's Landmark Decision: Mifepristone Secures Full Approval, Reshaping Reproductive Healthcare Landscape

Wockhardt Seeks USFDA Nod for Revolutionary Antibiotic Zaynich: A New Hope Against Superbugs

Historic Shift: FDA Greenlights Generic Abortion Pill, Redefining Access Landscape

Healthcare's Brink: How a Government Shutdown Threatens HHS, CDC, and FDA

Unveiling the Shadowy Ethics: Former Pharma CEO's FDA Claims Spark Regulatory Outcry

Ozempic Arrives in India: A New Dawn for Type 2 Diabetes Management and Weight Loss

MoonLake Immunotherapeutics Skyrockets: Is a Biotech Buyout Imminent After Breakthrough Skin Drug Trial?

Lupin Achieves Major Milestone: USFDA Grants Tentative Approval for Generic HIV Treatment Drug

European Triumph: KalVista and Ionis Celebrate Key Drug Approvals Across the EU

Market Movers: The Stocks Poised for Dynamic Action on September 15th

Controversial Critic Returns: Dr. Vinay Prasad Reassumes Key FDA Role

Game-Changer Alert: Travere Therapeutics Shares SOAR as FDA Fast-Tracks Rare Kidney Disease Drug Sparsentan!

A New Horizon for Lymphoma Patients: InnoCare's HIBRUCA Approved in Singapore for Marginal Zone Lymphoma

The Unprecedented Assault on Mifepristone: How a Lone Judge Ignited a National Firestorm Over Abortion Access

FDA Delivers Crushing Blow to Outlook Therapeutics: Eye Drug Approval for Wet AMD Declined

A New Dawn for Liver Health: FDA Greenlights Revolutionary MASH Treatment

Unveiling the Shadowy Ties: Conflicts of Interest at the FDA

The Silent Exodus: Alarming Purges of Scientists Threaten Public Health and Trust